Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world evaluation of CYP2C19 guided antiplatelet therapy in patients undergoing intracranial aneurysm repair.

Pharmacogenomics - 1 Jan 2024

Fox Layna P, Tunehag Kayla R, Nguyen Anh, Reed Samuel, Shastri Darshan, Quig Nathan, Stouffer George A, Solander Sten, Lee Craig R

Abstract excerpt

Aim: To evaluate the feasibility and impact of using CYP2C19 genotype to guide selection of antiplatelet therapy in patients undergoing intracranial aneurysm treatment with a flow diversion stent in a real-world clinical setting.Patients & methods: A single-center, retrospective, observational cohort study was conducted in 112 patients undergoing intracranial aneurysm repair with flow-diversion stenting from 2014...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Intracranial Aneurysm

Share to Platelet Aggregation Inhibitors

Share to Prasugrel Hydrochloride

Share to Stents

Share to Ticagrelor

Source

Open in PubMed Open full text

Identifiers

PMID: 39360670
DOI: 10.1080/14622416.2024.2406213
PMCID: PMC11760749

Genes

CYP2C19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world evaluation of CYP2C19 guided antiplatelet therapy in patients undergoing intracranial aneurysm repair.PMID 39360670Read ↗

Does the clopidogrel CYP2C19 genotype assay predict postprocedure stenosis in cerebral aneurysms treated with a flow diverter?Semantic proximity Read ↗

CYP2C19 genotype-guided antiplatelet therapy to prevent thromboembolic events after stent-assisted coil embolization of unruptured intracranial aneurysms: a retrospective cohort study.Semantic proximity Read ↗

CYP2C19 Genotype-Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure.Semantic proximity Read ↗

Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy.Semantic proximity Read ↗

CYP2C19 polymorphism and clinical outcomes of patients with carotid artery stentingSemantic proximity Read ↗

Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery Stenting.Semantic proximity Read ↗

Clinical Outcomes and Sustainability of Using CYP2C19 Genotype–Guided Antiplatelet Therapy After Percutaneous Coronary InterventionSemantic proximity Read ↗

Use of Tirofiban to Prevent Ischemic Events in Patients with CYP2C19 Loss-of-Function Alleles during Flow Diversion of Intracranial Aneurysm: A Multicenter Cohort Study.Semantic proximity Read ↗

Influence of CYP2C19 Phenotype on the Effect of Clopidogrel in Patients Undergoing a Percutaneous Neurointervention Procedure.Semantic proximity Read ↗

Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping.Semantic proximity Read ↗

The Role of Thrombin Time as an Independent Variable in Predicting In-Stent Stenosis Risk After Flow Diverter Treatment for Intracranial Aneurysms: A Retrospective Cohort StudySemantic proximity Read ↗

Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.